Australia's largest stock trading and investment forum Australia's #1 stock forum

MSB

Click for more information

9.09%

$1.26 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-258

First 258 Last

Share
Profile

Follow
Kingtup

1,652 Posts.

190

27/03/24

08:59

Post #: 73075639
Share

Originally posted by DocMcstuffins: ↑

Legit, I hope MSB gets the approval this time.

Maybe the FDA has changed its mind and decided it was purely the potency assay that was the issue.

The reason I'm skeptical is because less than a year ago, when the second CRL was issued, MSB said it would address the issues raised by performing another trial in adults in order to gather more evidence.

That has slowly morphed into just needing a potency assay. Without management explicitly saying that the FDA only requires this

After the first CRL, MSB said the FDA requested a further RCT for more evidence.

That then morphed into drudging through post hoc analysis, etc, and they reapplied a second time, and everyone was certain it would be enough.

Including Si.

I hope I'm wrong this time.

Expand

Who cares about your thoughts Dr McDuck. No one.

MSB Price at posting: 48.0¢ Sentiment: None Disclosure: Held
6 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 442 more messages in this thread...

First 258 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.26		Change 0.105(9.09%)		Mkt cap ! $1.438B

Open	High	Low	Value	Volume
$1.16	$1.30	$1.16	$21.76M	17.82M

Buyers (Bids)

No.	Vol.	Price($)
2	98636	$1.26

Sellers (Offers)

Price($)	Vol.	No.
$1.26	600000	1

View Market Depth

No.	Vol.	Price($)
2	98636	1.255
6	67800	1.250
2	13220	1.240
2	15000	1.225
2	6000	1.220

Price($)	Vol.	No.
1.260	600000	1
1.270	5014	1
1.275	13810	1
1.280	6000	2
1.285	40702	2

Last trade - 16.10pm 28/05/2024 (20 minute delay)


Last $1.27			Change 0.105 ( 9.35 %)
Open	High		Low	Volume
$1.17	$1.30		$1.16	2142493
Last updated 15.59pm 28/05/2024 ?

MSB (ASX) Chart

SPONSORED BY